SEPTEMBER 9, 2005 09:27 AM
Advice from Standard and Poors
MARKET MOVERS

Northrop Grumman Says Katrina Will Hurt Profits

Yellow Roadway adjusts its earnings guidance, Biogen Idec plans to cut its workforce by 17%, plus more companies in the news Friday



Northrop Grumman (NOC ) cut its earning per share guidance for 2005 by 6 cents to 12 cents, reflecting work delays and the negative impact of Hurricane Katrina. The technology services company sees lower-than-previosuly-guided revenue of $950 million, but expects its 2006 guidance will by largely unaffected by the hurricane.


Biogen Idec (BIIB ) is planning to cut its workforce by about 17% and will seek to divest several non-core assets. The biotech company's Executive Vice President of Research Michael Gilman is leaving. Thomas Weisel reportedly cut its opinion on the stock to underperform; Citigroup reportedly cut its opinion to hold.

Yellow Roadway (YELL ) said it expects third-quarter adjusted earnings per share of between $1.40 and $1.45 vs. previous guidance of $1.60 to $1.65. The company cited devastation caused by Hurricane Katrina, and implementation challenges for new processes at Roadway such as the associated learning curve.

Texas Instruments (TXN ) said it sees between 36 cents and 38 cents third-quarter earnings per share, including stock option expense, on revenue of between $3.48 billion and $3.62 billion. S&P raised its estimates and price target on the stock, but kept a hold investment recommendation.

Intel (INTC ) said it sees third-quarter revenue of between $9.8 billion and $10 billion, vs. its previous guidance of between $9.6 billion and $10.2 billion. The chip maker said its gross margin percentage is now expected to be 60%, plus or minus a point. S&P kept its hold opinion on the stock.

Martek Biosciences (MATK ) posted a breakeven third quarter, vs. 16 cents earnings per share, on 17% lower revenue. First Albany downgraded the stock to neutral from buy.

Molex (MOLX ) posted 27 cents, vs. 30 cents, fourth-quarter earnings per share (before charges) despite a slight sales rise. S&P upgraded the stock to hold from sell.

Open Text (OTEX ) posted 10 cents, vs. 16 cents, fourth-quarter earnings per share (based on Generally Accepted Accounting Principles) despite a 4% rise in revenue. The software company sees first-quarter adjusted earnings per share of 4 cents to 15 cents on revenue of between $85 million and $95 million. It also expects to take the majority of a $25 million to $30 million restructuring charge in the first quarter. Jefferies upped its opinion on the stock to hold from underperform.

Cascade (CAE ) posted 84 cents, vs. 51 cents, second quarter earnings per share on a 24% sales rise.

Progenics Pharmaceuticals (PGNX ) announced positive clinical findings regarding its investigational drug, PRO 140, which is a novel HIV entry inhibitor.

Brinker (EAT ) posted 3.2% higher August same-store sales and raised its first-quarter earnings per share guidance to between 47 cents and 48 cents, excluding equity-based compensation expense.

Avid Technology (AVID ) signed a multimillion dollar broadcast deal with CBS to install its end-to-end digital newsroom environments at the network's New York City headquarters and London news bureau.

Biovail ( BVF ) said its New Drug Application for the once-daily formulation of tramadol hydrochloride received final approval from the Food and Drug Administration for the treatment of moderate to moderately severe chronic pain.

Quiksilver (ZQK ) posted 20 cents, vs. 16 cents, third-quarter earnings per share on an 11% revenue rise. The company sees 26 cents to 27 cents fourth quarter earnings per share and 86 cents to 87 cents fiscal year 2005 earnings per share.




All of the views expressed in this research report accurately reflect the research analyst's personal views regarding any and all of the subject securities or issuers. No part of analyst compensation was, is or will be, directly or indirectly related to the specific recommendations or views expressed in this research report.
Standard & Poor's Regulatory Disclosure

Any advice, analysis, or recommendations contained in articles labeled "Insight from Standard & Poor's" reflect the views of Standard & Poor's, which operates separately from and independently of BusinessWeek Online. It is possible that BWOL may from time to time publish information that is not consistent with advice, analysis, or recommendations that are published by Standard & Poor's. Standard & Poor's and BusinessWeek Online are each units of The McGraw-Hill Companies, Inc.


Get BusinessWeek directly on your desktop with our RSS feeds.XML

Add BusinessWeek news to your Web site with our headline feed.

Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video.

To subscribe online to BusinessWeek magazine, please click here.

Learn more, go to the BusinessWeekOnline home page

Back to Top


  MARKET INFO
DJIA 0 0.00
S&P 500 0 0.00
Nasdaq 0 0.00

Portfolio Service Update

Stock Lookup

Enter name or ticker



Media Kit | Special Sections | MarketPlace | Knowledge Centers
Bloomberg L.P.